Since the human genome was successfully sequenced, a whole new world of possibilities has opened up for understanding and potentially treating genetic disorders. If the human body is like any other machine and operates according to a (highly complex) code, then once that code has been cracked, it may be possible to demystify its complexity by rewriting it or erasing mistakes. These possibilities are getting patients, doctors and researchers very excited. One of the leading companies with the technology and expertise to enable researchers to sequence, edit and write DNA is Thermo Fisher Scientific, a company with 17 billion USD in turnover and more than 50,000 employees worldwide.
Webcode:
To read an article from the print magazine online, please enter the web code below, which can be found in the magazine under the article.
